While our metabolic analysis primarily relies on [U-13C]-glutamine tracing to assess the role of LINC02802 and SLC25A51 in NSCLC metabolism, we acknowledge that incorporating additional tracers such as [U-13C]-glucose or [U-13C]-acetate would provide a more comprehensive view of carbon flux and help rule out alternative metabolic pathways. Here, SLC25A51 is linked to non-small cell lung carcinoma.